Review of Ets1 structure, function, and roles in immunity

Cellular and Molecular Life Sciences

Volumn 70, Issue 18, 2013, Pages 3375-3390

  Garrett Sinha, Lee Ann ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

B lymphocyte; Ets1; Gene regulation; Transcription factor

Indexed keywords

CD4 ANTIGEN; PROTEIN P54; SUMO PROTEIN; TRANSCRIPTION FACTOR ETS 1; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR RUNX1; UBIQUITIN CONJUGATING ENZYME; UPSTREAM STIMULATORY FACTOR;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; B CELL LYMPHOMA; B LYMPHOCYTE DIFFERENTIATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; GENE FREQUENCY; GENE LOCUS; GENE TARGETING; HEMATOLOGIC MALIGNANCY; HUMAN; HUMORAL IMMUNITY; IMMUNOREGULATION; MALIGNANT TRANSFORMATION; NATURAL KILLER CELL; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SUMOYLATION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; UBIQUITINATION;

ALLELES; ANIMALS; AUTOIMMUNITY; B-LYMPHOCYTES; CELL TRANSFORMATION, NEOPLASTIC; CHICKENS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KILLER CELLS, NATURAL; MICE; OPOSSUMS; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEIN C-ETS-1; SUMO-1 PROTEIN; T-LYMPHOCYTES; UBIQUITIN;

EID: 84883466291     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-012-1243-7     Document Type: Review

References (162)

1. King N, Westbrook MJ, Young SL, Kuo A, Abedin M, Chapman J, Fairclough S, Hellsten U, Isogai Y, Letunic I, Marr M, Pincus D, Putnam N, Rokas A, Wright KJ, Zuzow R, Dirks W, Good M, Goodstein D, Lemons D, Li W, Lyons JB, Morris A, Nichols S, Richter DJ, Salamov A, Sequencing JG, Bork P, Lim WA, Manning G, Miller WT, McGinnis W, Shapiro H, Tjian R, Grigoriev IV, Rokhsar D (2008) The genome of the choanoflagellate Monosiga brevicollis and the origin of metazoans. Nature 451(7180):783-788. doi: 10.1038/nature06617
2. Aravind L, Anantharaman V, Balaji S, Babu MM, Iyer LM (2005) The many faces of the helix-turn-helix domain: transcription regulation and beyond. FEMS Microbiol Rev 29(2):231-262. doi: 10.1016/j.femsre.2004.12.008
3. Lautenberger JA, Burdett LA, Gunnell MA, Qi S, Watson DK, O'Brien SJ, Papas TS (1992) Genomic dispersal of the ets gene family during metazoan evolution. Oncogene 7(9):1713-1719
4. Hsu T, Schulz RA (2000) Sequence and functional properties of Ets genes in the model organism Drosophila. Oncogene 19(55):6409-6416
5. Wei G, Srinivasan R, Cantemir-Stone CZ, Sharma SM, Santhanam R, Weinstein M, Muthusamy N, Man AK, Oshima RG, Leone G, Ostrowski MC (2009) Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis. Blood 114(5):1123-1130. doi: 10.1182/blood-2009-03-211391
6. Leprince D, Duterque-Coquillaud M, Li RP, Henry C, Flourens A, Debuire B, Stehelin D (1988) Alternative splicing within the chicken c-ets-1 locus: implications for transduction within the E26 retrovirus of the c-ets proto-oncogene. J Virol 62(9):3233-3241
7. Albagli O, Soudant N, Ferreira E, Dhordain P, Dewitte F, Begue A, Flourens A, Stehelin D, Leprince D (1994) A model for gene evolution of the ets-1/ets-2 transcription factors based on structural and functional homologies. Oncogene 9(11):3259-3271
8. Jorcyk CL, Garrett LJ, Maroulakou IG, Watson DK, Green JE (1997) Multiple regulatory regions control the expression of Ets-1 in the developing mouse: vascular expression conferred by intron I. Cell Mol Biol(Noisy-le-grand) 43(2):211-225
9. Wasylyk C, Kerckaert JP, Wasylyk B (1992) A novel modulator domain of Ets transcription factors. Genes Dev 6(6):965-974
10. Laitem C, Leprivier G, Choul-Li S, Begue A, Monte D, Larsimont D, Dumont P, Duterque-Coquillaud M, Aumercier M (2009) Ets-1 p27: a novel Ets-1 isoform with dominant-negative effects on the transcriptional properties and the subcellular localization of Ets-1 p51. Oncogene 28(20):2087-2099. doi: 10.1038/onc.2009.72
11. Donaldson LW, Petersen JM, Graves BJ, McIntosh LP (1994) Secondary structure of the ETS domain places murine Ets-1 in the superfamily of winged helix-turn-helix DNA-binding proteins. Biochemistry 33(46):13509-13516
12. Fisher RJ, Koizumi S, Kondoh A, Mariano JM, Mavrothalassitis G, Bhat NK, Papas TS (1992) Human ETS1 oncoprotein. Purification, isoforms, -SH modification, and DNA sequence-specific binding. J Biol Chem 267(25):17957-17965
13. Hagman J, Grosschedl R (1992) An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene. Proc Natl Acad Sci USA 89(19):8889-8893
14. Nye JA, Petersen JM, Gunther CV, Jonsen MD, Graves BJ (1992) Interaction of murine ets-1 with GGA-binding sites establishes the ETS domain as a new DNA-binding motif. Genes Dev 6(6):975-990
15. Skalicky JJ, Donaldson LW, Petersen JM, Graves BJ, McIntosh LP (1996) Structural coupling of the inhibitory regions flanking the ETS domain of murine Ets-1. Protein Sci 5(2):296-309
16. Donaldson LW, Petersen JM, Graves BJ, McIntosh LP (1996) Solution structure of the ETS domain from murine Ets-1: a winged helix-turn-helix DNA binding motif. EMBO J 15(1):125-134
17. Jonsen MD, Petersen JM, Xu QP, Graves BJ (1996) Characterization of the cooperative function of inhibitory sequences in Ets-1. Mol Cell Biol 16(5):2065-2073
18. Pognonec P, Boulukos KE, Gesquiere JC, Stehelin D, Ghysdael J (1988) Mitogenic stimulation of thymocytes results in the calcium-dependent phosphorylation of c-ets-1 proteins. EMBO J 7(4):977-983
19. Rabault B, Ghysdael J (1994) Calcium-induced phosphorylation of ETS1 inhibits its specific DNA binding activity. J Biol Chem 269(45):28143-28151
20. Valentine MA, Czernik AJ, Rachie N, Hidaka H, Fisher CL, Cambier JC, Bomsztyk K (1995) Anti-immunoglobulin M activates nuclear calcium/calmodulin- dependent protein kinase II in human B lymphocytes. J Exp Med 182(6):1943-1949
21. Fisher CL, Ghysdael J, Cambier JC (1991) Ligation of membrane Ig leads to calcium-mediated phosphorylation of the proto-oncogene product, Ets-1. J Immunol 146(6):1743-1749
22. Fisher RJ, Fivash M, Casas-Finet J, Erickson JW, Kondoh A, Bladen SV, Fisher C, Watson DK, Papas T (1994) Real-time DNA binding measurements of the ETS1 recombinant oncoproteins reveal significant kinetic differences between the p42 and p51 isoforms. Protein Sci 3(2):257-266
23. Pognonec P, Boulukos KE, Ghysdael J (1989) The c-ets-1 protein is chromatin associated and binds to DNA in vitro. Oncogene 4(6):691-697
24. Cowley DO, Graves BJ (2000) Phosphorylation represses Ets-1 DNA binding by reinforcing autoinhibition. Genes Dev 14(3):366-376
25. Hodge DR, Robinson L, Watson D, Lautenberger J, Zhang XK, Venanzoni M, Seth A (1996) Interaction of ETS-1 and ERGB/FLI-1 proteins with DNA is modulated by spacing between multiple binding sites as well as phosphorylation. Oncogene 12(1):11-18
26. Hollenhorst PC, McIntosh LP, Graves BJ (2011) Genomic and biochemical insights into the specificity of ETS transcription factors. Annu Rev Biochem 80:437-471. doi: 10.1146/annurev.biochem.79.081507.103945
27. Kim WY, Sieweke M, Ogawa E, Wee HJ, Englmeier U, Graf T, Ito Y (1999) Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains. EMBO J 18(6):1609-1620
28. Tian G, Erman B, Ishii H, Gangopadhyay SS, Sen R (1999) Transcriptional activation by ETS and leucine zipper-containing basic helix-loop-helix proteins. Mol Cell Biol 19(4):2946-2957
29. Goetz TL, Gu TL, Speck NA, Graves BJ (2000) Auto-inhibition of Ets-1 is counteracted by DNA binding cooperativity with core-binding factor alpha2. Mol Cell Biol 20(1):81-90
30. Fitzsimmons D, Lukin K, Lutz R, Garvie CW, Wolberger C, Hagman J (2009) Highly cooperative recruitment of Ets-1 and release of autoinhibition by Pax5. J Mol Biol 392(2):452-464. doi: 10.1016/j.jmb.2009.07.028
31. Baillat D, Begue A, Stehelin D, Aumercier M (2002) ETS-1 transcription factor binds cooperatively to the palindromic head to head ETS-binding sites of the stromelysin-1 promoter by counteracting autoinhibition. J Biol Chem 277(33):29386-29398
32. Gegonne A, Punyammalee B, Rabault B, Bosselut R, Seneca S, Crabeel M, Ghysdael J (1992) Analysis of the DNA binding and transcriptional activation properties of the Ets1 oncoprotein. New Biol 4(5):512-519
33. Schneikert J, Lutz Y, Wasylyk B (1992) Two independent activation domains in c-Ets-1 and c-Ets-2 located in non-conserved sequences of the ets gene family. Oncogene 7(2):249-256
34. Klambt C (1993) The Drosophila gene pointed encodes two ETS-like proteins which are involved in the development of the midline glial cells. Development 117(1):163-176
35. Kasten M, Giordano A (2001) Cdk10, a Cdc2-related kinase, associates with the Ets2 transcription factor and modulates its transactivation activity. Oncogene 20(15):1832-1838. doi: 10.1038/sj.onc.1204295
36. Seidel JJ, Graves BJ (2002) An ERK2 docking site in the Pointed domain distinguishes a subset of ETS transcription factors. Genes Dev 16(1):127-137
37. Mackereth CD, Scharpf M, Gentile LN, MacIntosh SE, Slupsky CM, McIntosh LP (2004) Diversity in structure and function of the Ets family PNT domains. J Mol Biol 342(4):1249-1264
38. Rabault B, Roussel MF, Quang CT, Ghysdael J (1996) Phosphorylation of Ets1 regulates the complementation of a CSF-1 receptor impaired in mitogenesis. Oncogene 13(4):877-881
39. Yang BS, Hauser CA, Henkel G, Colman MS, Van Beveren C, Stacey KJ, Hume DA, Maki RA, Ostrowski MC (1996) Ras-mediated phosphorylation of a conserved threonine residue enhances the transactivation activities of c-Ets1 and c-Ets2. Mol Cell Biol 16(2):538-547
40. Wasylyk C, Bradford AP, Gutierrez-Hartmann A, Wasylyk B (1997) Conserved mechanisms of Ras regulation of evolutionary related transcription factors, Ets1 and Pointed P2. Oncogene 14(8):899-913
41. Nelson ML, Kang HS, Lee GM, Blaszczak AG, Lau DK, McIntosh LP, Graves BJ (2010) Ras signaling requires dynamic properties of Ets1 for phosphorylation-enhanced binding to coactivator CBP. Proc Natl Acad Sci USA 107(22):10026-10031. doi: 10.1073/pnas.0915137107
42. Jayaraman G, Srinivas R, Duggan C, Ferreira E, Swaminathan S, Somasundaram K, Williams J, Hauser C, Kurkinen M, Dhar R, Weitzman S, Buttice G, Thimmapaya B (1999) p300/cAMP-responsive element-binding protein interactions with ets-1 and ets-2 in the transcriptional activation of the human stromelysin promoter. J Biol Chem 274(24):17342-17352
43. Foulds CE, Nelson ML, Blaszczak AG, Graves BJ (2004) Ras/mitogen- activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment. Mol Cell Biol 24(24):10954-10964
44. Hahn SL, Wasylyk B, Criqui-Filipe P (1997) Modulation of ETS-1 transcriptional activity by huUBC9, a ubiquitin-conjugating enzyme. Oncogene 15(12):1489-1495. doi: 10.1038/sj.onc.1201301
45. Nishida T, Terashima M, Fukami K (2006) PIASy-mediated repression of the Ets-1 is independent of its sumoylation. Biochem Biophys Res Commun 345(4):1536-1546
46. Ji Z, Degerny C, Vintonenko N, Deheuninck J, Foveau B, Leroy C, Coll J, Tulasne D, Baert JL, Fafeur V (2007) Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation. Oncogene 26(3):395-406. doi: 10.1038/sj.onc.1209789
47. Escobar-Cabrera E, Okon M, Lau DK, Dart CF, Bonvin AM, McIntosh LP (2011) Characterizing the N- and C-terminal Small ubiquitin-like modifier (SUMO)-interacting motifs of the scaffold protein DAXX. J Biol Chem 286(22):19816-19829. doi: 10.1074/jbc.M111.231647
48. Macauley MS, Errington WJ, Scharpf M, Mackereth CD, Blaszczak AG, Graves BJ, McIntosh LP (2006) Beads-on-a-string, characterization of ETS-1 sumoylated within its flexible N-terminal sequence. J Biol Chem 281(7):4164-4172
49. Nishida T, Terashima M, Fukami K, Yamada Y (2007) PIASy controls ubiquitination-dependent proteasomal degradation of Ets-1. Biochem J 405(3):481-488. doi: 10.1042/BJ20070026
50. Kola I, Brookes S, Green AR, Garber R, Tymms M, Papas TS, Seth A (1993) The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation. Proc Natl Acad Sci USA 90(16):7588-7592
51. Maroulakou IG, Papas TS, Green JE (1994) Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis. Oncogene 9(6):1551-1565
52. Bhat NK, Fisher RJ, Fujiwara S, Ascione R, Papas TS (1987) Temporal and tissue-specific expression of mouse ets genes. Proc Natl Acad Sci USA 84(10):3161-3165
53. Bhat NK, Komschlies KL, Fujiwara S, Fisher RJ, Mathieson BJ, Gregorio TA, Young HA, Kasik JW, Ozato K, Papas TS (1989) Expression of ets genes in mouse thymocyte subsets and T cells. J Immunol 142(2):672-678
54. Maroulakou IG, Bowe DB (2000) Expression and function of Ets transcription factors in mammalian development: a regulatory network. Oncogene 19(55):6432-6442
55. Sacchi N, de Klein A, Showalter SD, Bigi G, Papas TS (1988) High expression of ets-1 gene in human thymocytes and immature T leukemic cells. Leukemia 2(1):12-18
56. Chen JH (1985) The proto-oncogene c-ets is preferentially expressed in lymphoid cells. Mol Cell Biol 5(11):2993-3000
57. Ghysdael J, Gegonne A, Pognonec P, Dernis D, Leprince D, Stehelin D (1986) Identification and preferential expression in thymic and bursal lymphocytes of a c-ets oncogene-encoded Mr 54,000 cytoplasmic protein. Proc Natl Acad Sci USA 83(6):1714-1718
58. Anderson MK, Hernandez-Hoyos G, Diamond RA, Rothenberg EV (1999) Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage. Development 126(14):3131-3148
59. Faust EA, Saffran DC, Toksoz D, Williams DA, Witte ON (1993) Distinctive growth requirements and gene expression patterns distinguish progenitor B cells from pre-B cells. J Exp Med 177(4):915-923
60. Barton K, Muthusamy N, Fischer C, Ting CN, Walunas TL, Lanier LL, Leiden JM (1998) The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity 9(4):555-563
61. Dreyfus F, Picard F, Gisselbrecht S, Varet B, Tambourin PE, Fichelson S (1989) ets-1 and ets-2 proto-oncogene expression in human leukemia cells and cell lines. Nouv Rev Fr Hematol 31(3):217-221
62. John SA, Clements JL, Russell LM, Garrett-Sinha LA (2008) Ets-1 regulates plasma cell differentiation by interfering with the activity of the transcription factor Blimp-1. J Biol Chem 283(2):951-962. doi: 10.1074/jbc.M705262200
63. Hultgardh-Nilsson A, Cercek B, Wang JW, Naito S, Lovdahl C, Sharifi B, Forrester JS, Fagin JA (1996) Regulated expression of the ets-1 transcription factor in vascular smooth muscle cells in vivo and in vitro. Circ Res 78(4):589-595
64. Ni W, Zhan Y, He H, Maynard E, Balschi JA, Oettgen P (2007) Ets-1 is a critical transcriptional regulator of reactive oxygen species and p47(phox) gene expression in response to angiotensin II. Circ Res 101(10):985-994. doi: 10.1161/CIRCRESAHA.107.152439
65. Inaba H, Kuboniwa M, Sugita H, Lamont RJ, Amano A (2012) Identification of signaling pathways mediating cell cycle arrest and apoptosis induced by Porphyromonas gingivalis in human trophoblasts. Infect Immun 80(8):2847-2857. doi: 10.1128/IAI.00258-12
66. Leprince D, Gesquiere JC, Stehelin D (1990) The chicken cellular progenitor of the v-ets oncogene, p68c-ets-1, is a nuclear DNA-binding protein not expressed in lymphoid cells of the spleen. Oncogene Res 5(4):255-265
67. Bhattacharya D, Cheah MT, Franco CB, Hosen N, Pin CL, Sha WC, Weissman IL (2007) Transcriptional profiling of antigen-dependent murine B cell differentiation and memory formation. J Immunol 179(10):6808-6819 179/10/6808 [pii]
68. Bhat NK, Thompson CB, Lindsten T, June CH, Fujiwara S, Koizumi S, Fisher RJ, Papas TS (1990) Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: regulatory role for the protooncogene ETS1. Proc Natl Acad Sci USA 87(10):3723-3727
69. Bories JC, Willerford DM, Grevin D, Davidson L, Camus A, Martin P, Stehelin D, Alt FW (1995) Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature 377(6550):635-638
70. Muthusamy N, Barton K, Leiden JM (1995) Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature 377(6550):639-642
71. Wang D, John SA, Clements JL, Percy DH, Barton KP, Garrett-Sinha LA (2005) Ets-1 deficiency leads to altered B cell differentiation, hyperresponsiveness to TLR9 and autoimmune disease. Int Immunol 17(9):1179-1191
72. Xu D, Wilson TJ, Chan D, De Luca E, Zhou J, Hertzog PJ, Kola I (2002) Ets1 is required for p53 transcriptional activity in UV-induced apoptosis in embryonic stem cells. EMBO J 21(15):4081-4093
73. Lim F, Kraut N, Framptom J, Graf T (1992) DNA binding by c-Ets-1, but not v-Ets, is repressed by an intramolecular mechanism. EMBO J 11(2):643-652
74. Pognonec P, Boulukos KE, Bosselut R, Boyer C, Schmitt-Verhulst AM, Ghysdael J (1990) Identification of a Ets1 variant protein unaffected in its chromatin and in vitro DNA binding capacities by T cell antigen receptor triggering and intracellular calcium rises. Oncogene 5(4):603-610
75. Higuchi T, Bartel FO, Masuya M, Deguchi T, Henderson KW, Li R, Muise-Helmericks RC, Kern MJ, Watson DK, Spyropoulos DD (2007) Thymomegaly, microsplenia and defective homeostatic proliferation of peripheral lymphocytes in p51-Ets1 isoform-specific null mice. Mol Cell Biol 27(9):3353-3366
76. Russell L, Garrett-Sinha LA (2010) Transcription factor Ets-1 in cytokine and chemokine gene regulation. Cytokine 51(3):217-226. doi: 10.1016/j.cyto.2010.03.006
77. Li Q, Eppolito C, Odunsi K, Shrikant PA (2010) Antigen-induced Erk1/2 activation regulates Ets-1-mediated sensitization of CD8+ T cells for IL-12 responses. J Leukoc Biol 87(2):257-263. doi: 10.1189/jlb.0409221
78. Zamisch M, Tian L, Grenningloh R, Xiong Y, Wildt KF, Ehlers M, Ho IC, Bosselut R (2009) The transcription factor Ets1 is important for CD4 repression and Runx3 up-regulation during CD8 T cell differentiation in the thymus. J Exp Med 206(12):2685-2699. doi: 10.1084/jem.20092024
79. Nagaleekar VK, Diehl SA, Juncadella I, Charland C, Muthusamy N, Eaton S, Haynes L, Garrett-Sinha LA, Anguita J, Rincon M (2008) IP3 receptor-mediated Ca2+ release in naive CD4 T cells dictates their cytokine program. J Immunol 181(12):8315-8322 181/12/8315 [pii]
80. Moisan J, Grenningloh R, Bettelli E, Oukka M, Ho IC (2007) Ets-1 is a negative regulator of Th17 differentiation. J Exp Med 204(12):2825-2835
81. Clements JL, John SA, Garrett-Sinha LA (2006) Impaired generation of CD8+ thymocytes in Ets-1-deficient mice. J Immunol 177(2):905-912
82. Grenningloh R, Kang BY, Ho IC (2005) Ets-1, a functional cofactor of T-bet, is essential for Th1 inflammatory responses. J Exp Med 201(4):615-626
83. Eyquem S, Chemin K, Fasseu M, Bories JC (2004) The Ets-1 transcription factor is required for complete pre-T cell receptor function and allelic exclusion at the T cell receptor beta locus. Proc Natl Acad Sci USA 101(44):15712-15717
84. Grenningloh R, Tai TS, Frahm N, Hongo TC, Chicoine AT, Brander C, Kaufmann DE, Ho IC (2011) Ets-1 maintains IL-7 receptor expression in peripheral T cells. J Immunol 186(2):969-976. doi: 10.4049/jimmunol.1002099
85. Mouly E, Chemin K, Nguyen HV, Chopin M, Mesnard L, Leite-de-Moraes M, Burlen-Defranoux O, Bandeira A, Bories JC (2010) The Ets-1 transcription factor controls the development and function of natural regulatory T cells. J Exp Med 207(10):2113-2125. doi: 10.1084/jem.20092153
86. Polansky JK, Schreiber L, Thelemann C, Ludwig L, Kruger M, Baumgrass R, Cording S, Floess S, Hamann A, Huehn J (2010) Methylation matters: binding of Ets-1 to the demethylated Foxp3 gene contributes to the stabilization of Foxp3 expression in regulatory T cells. J Mol Med 88(10):1029-1040. doi: 10.1007/s00109-010-0642-1
87. Boyman O, Sprent J (2012) The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol 12(3):180-190. doi: 10.1038/nri3156
88. Lee CG, Kwon HK, Sahoo A, Hwang W, So JS, Hwang JS, Chae CS, Kim GC, Kim JE, So HS, Hwang ES, Grenningloh R, Ho IC, Im SH (2012) Interaction of Ets-1 with HDAC1 represses IL-10 expression in Th1 cells. J Immunol 188(5):2244-2253. doi: 10.4049/jimmunol.1101614
89. Hambor JE, Mennone J, Coon ME, Hanke JH, Kavathas P (1993) Identification and characterization of an Alu-containing, T-cell-specific enhancer located in the last intron of the human CD8 alpha gene. Mol Cell Biol 13(11):7056-7070
90. Nguyen HV, Mouly E, Chemin K, Luinaud R, Despres R, Fermand JP, Arnulf B, Bories JC (2012) The Ets-1 transcription factor is required for Stat1-mediated T-bet expression and IgG2a class switching in mouse B cells. Blood 119(18):4174-4181. doi: 10.1182/blood-2011-09-378182
91. Eyquem S, Chemin K, Fasseu M, Chopin M, Sigaux F, Cumano A, Bories JC (2004) The development of early and mature B cells is impaired in mice deficient for the Ets-1 transcription factor. Eur J Immunol 34(11):3187-3196
92. Ramirez K, Chandler KJ, Spaulding C, Zandi S, Sigvardsson M, Graves BJ, Kee BL (2012) Gene deregulation and chronic activation in natural killer cells deficient in the transcription factor ETS1. Immunity 36(6):921-932. doi: 10.1016/j.immuni.2012.04.006
93. Walunas TL, Wang B, Wang CR, Leiden JM (2000) Cutting edge: the Ets1 transcription factor is required for the development of NK T cells in mice. J Immunol 164(6):2857-2860
94. Georgiou P, Maroulakou I, Green J, Dantis P, Romanospica V, Kottaridis S, Lautenberger J, Watson D, Papas T, Fischinger P, Bhat N (1996) Expression of ets family of genes in systemic lupus erythematosus and Sjögren's syndrome. Int J Oncol 9(1):9-18
95. Pearce RB (1998) Fine-mapping of the mouse T lymphocyte fraction (Tlf) locus on chromosome 9: association with autoimmune diabetes. Autoimmunity 28(1):31-45
96. Prochazka M, Leiter EH, Serreze DV, Coleman DL (1987) Three recessive loci required for insulin-dependent diabetes in nonobese diabetic mice. Science 237(4812):286-289
97. Prochazka M, Leiter E (1989) Mapping of Ldlr, Ets-1, T3d and T3e genes to the proximal region of Chromosome 9 in a linkage analysis of Idd-2 locus in NOD/Lt mice. Mouse News Lett 84:91
98. Jordan MA, Poulton LD, Fletcher JM, Baxter AG (2009) Allelic variation of Ets1 does not contribute to NK and NKT cell deficiencies in type 1 diabetes susceptible NOD mice. Rev Diabet Stud 6(2):104-116. doi: 10.1900/RDS.2009.6.104
99. Aparicio JM, Wakisaka A, Takada A, Matsuura N, Yoshiki T (1990) Non-HLA genetic factors and insulin dependent diabetes mellitus in the Japanese: TCRA, TCRB and TCRG, INS, THY1, CD3D and ETS1. Dis Markers 8(5):283-294
100. Sullivan KE, Piliero LM, Dharia T, Goldman D, Petri MA (2000) 3′ polymorphisms of ETS1 are associated with different clinical phenotypes in SLE. Hum Mutat 16(1):49-53
101. Han JW, Zheng HF, Cui Y, Sun LD, Ye DQ, Hu Z, Xu JH, Cai ZM, Huang W, Zhao GP, Xie HF, Fang H, Lu QJ, Li XP, Pan YF, Deng DQ, Zeng FQ, Ye ZZ, Zhang XY, Wang QW, Hao F, Ma L, Zuo XB, Zhou FS, Du WH, Cheng YL, Yang JQ, Shen SK, Li J, Sheng YJ, Zuo XX, Zhu WF, Gao F, Zhang PL, Guo Q, Li B, Gao M, Xiao FL, Quan C, Zhang C, Zhang Z, Zhu KJ, Li Y, Hu DY, Lu WS, Huang JL, Liu SX, Li H, Ren YQ, Wang ZX, Yang CJ, Wang PG, Zhou WM, Lv YM, Zhang AP, Zhang SQ, Lin D, Low HQ, Shen M, Zhai ZF, Wang Y, Zhang FY, Yang S, Liu JJ, Zhang XJ (2009) Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet 41(11):1234-1237. doi: 10.1038/ng.472
102. Yang W, Shen N, Ye DQ, Liu Q, Zhang Y, Qian XX, Hirankarn N, Ying D, Pan HF, Mok CC, Chan TM, Wong RW, Lee KW, Mok MY, Wong SN, Leung AM, Li XP, Avihingsanon Y, Wong CM, Lee TL, Ho MH, Lee PP, Chang YK, Li PH, Li RJ, Zhang L, Wong WH, Ng IO, Lau CS, Sham PC, Lau YL (2010) Genome-wide association study in Asian populations identifies variants in ETS1 and WDFY4 associated with systemic lupus erythematosus. PLoS Genet 6(2):e1000841. doi: 10.1371/journal.pgen.1000841
103. Li Y, Sun LD, Lu WS, Hu WL, Gao JP, Cheng YL, Yu ZY, Yao S, He CF, Liu JL, Cui Y, Yang S (2010) Expression analysis of ETS1 gene in peripheral blood mononuclear cells with systemic lupus erythematosus by real-time reverse transcription PCR. Chin Med J (Engl) 123(16):2287-2288
104. Zhong H, Li XL, Li M, Hao LX, Chen RW, Xiang K, Qi XB, Ma RZ, Su B (2011) Replicated associations of TNFAIP3, TNIP1 and ETS1 with systemic lupus erythematosus in a southwestern Chinese population. Arthritis Res Ther 13(6):R186. doi: 10.1186/ar3514
105. He CF, Liu YS, Cheng YL, Gao JP, Pan TM, Han JW, Quan C, Sun LD, Zheng HF, Zuo XB, Xu SX, Sheng YJ, Yao S, Hu WL, Li Y, Yu ZY, Yin XY, Zhang XJ, Cui Y, Yang S (2010) TNIP1, SLC15A4, ETS1, RasGRP3 and IKZF1 are associated with clinical features of systemic lupus erythematosus in a Chinese Han population. Lupus 19(10):1181-1186. doi: 10.1177/0961203310367918
106. Wang C, Ahlford A, Järvinen TM, Nordmark G, Eloranta ML, Gunnarsson I, Svenungsson E, Padyukov L, Sturfelt G, Jönsen A, Bengtsson AA, Truedsson L, Eriksson C, Rantapää-Dahlqvist S, Sjöwall C, Julkunen H, Criswell LA, Graham RR, Behrens TW, Kere J, Rönnblom L, Syvänen AC, Sandling JK (2012) Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populations. Eur J Hum Genet. doi: 10.1038/ejhg.2012.277
107. Okada Y, Terao C, Ikari K, Kochi Y, Ohmura K, Suzuki A, Kawaguchi T, Stahl EA, Kurreeman FA, Nishida N, Ohmiya H, Myouzen K, Takahashi M, Sawada T, Nishioka Y, Yukioka M, Matsubara T, Wakitani S, Teshima R, Tohma S, Takasugi K, Shimada K, Murasawa A, Honjo S, Matsuo K, Tanaka H, Tajima K, Suzuki T, Iwamoto T, Kawamura Y, Tanii H, Okazaki Y, Sasaki T, Gregersen PK, Padyukov L, Worthington J, Siminovitch KA, Lathrop M, Taniguchi A, Takahashi A, Tokunaga K, Kubo M, Nakamura Y, Kamatani N, Mimori T, Plenge RM, Yamanaka H, Momohara S, Yamada R, Matsuda F, Yamamoto K (2012) Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population. Nat Genet 44(5):511-516. doi: 10.1038/ng.2231
108. Tsoi LC, Spain SL, Knight J, Ellinghaus E, Stuart PE, Capon F, Ding J, Li Y, Tejasvi T, Gudjonsson JE, Kang HM, Allen MH, McManus R, Novelli G, Samuelsson L, Schalkwijk J, Stahle M, Burden AD, Smith CH, Cork MJ, Estivill X, Bowcock AM, Krueger GG, Weger W, Worthington J, Tazi-Ahnini R, Nestle FO, Hayday A, Hoffmann P, Winkelmann J, Wijmenga C, Langford C, Edkins S, Andrews R, Blackburn H, Strange A, Band G, Pearson RD, Vukcevic D, Spencer CC, Deloukas P, Mrowietz U, Schreiber S, Weidinger S, Koks S, Kingo K, Esko T, Metspalu A, Lim HW, Voorhees JJ, Weichenthal M, Wichmann HE, Chandran V, Rosen CF, Rahman P, Gladman DD, Griffiths CE, Reis A, Kere J, Duffin KC, Helms C, Goldgar D, Li Y, Paschall J, Malloy MJ, Pullinger CR, Kane JP, Gardner J, Perlmutter A, Miner A, Feng BJ, Hiremagalore R, Ike RW, Christophers E, Henseler T, Ruether A, Schrodi SJ, Prahalad S, Guthery SL, Fischer J, Liao W, Kwok P, Menter A, Lathrop GM, Wise C, Begovich AB, Onoufriadis A, Weale ME, Hofer A, Salmhofer W, Wolf P, Kainu K, Saarialho-Kere U, Suomela S, Badorf P, Huffmeier U, Kurrat W, Kuster W, Lascorz J, Mossner R, Schurmeier-Horst F, Stander M, Traupe H, Bergboer JG, Heijer MD, van de Kerkhof PC, Zeeuwen PL, Barnes L, Campbell LE, Cusack C, Coleman C, Conroy J, Ennis S, Fitzgerald O, Gallagher P, Irvine AD, Kirby B, Markham T, McLean WH, McPartlin J, Rogers SF, Ryan AW, Zawirska A, Giardina E, Lepre T, Perricone C, Martin-Ezquerra G, Pujol RM, Riveira-Munoz E, Inerot A, Naluai AT, Mallbris L, Wolk K, Leman J, Barton A, Warren RB, Young HS, Ricano-Ponce I, Trynka G, Pellett FJ, Henschel A, Aurand M, Bebo B, Gieger C, Illig T, Moebus S, Jockel KH, Erbel R, Donnelly P, Peltonen L, Blackwell JM, Bramon E, Brown MA, Casas JP, Corvin A, Craddock N, Duncanson A, Jankowski J, Markus HS, Mathew CG, McCarthy MI, Palmer CN, Plomin R, Rautanen A, Sawcer SJ, Samani N, Viswanathan AC, Wood NW, Bellenguez C, Freeman C, Hellenthal G, Giannoulatou E, Pirinen M, Su Z, Hunt SE, Gwilliam R, Bumpstead SJ, Dronov S, Gillman M, Gray E, Hammond N, Jayakumar A, McCann OT, Liddle J, Perez ML, Potter SC, Ravindrarajah R, Ricketts M, Waller M, Weston P, Widaa S, Whittaker P, Nair RP, Franke A, Barker JN, Abecasis GR, Elder JT, Trembath RC (2012) Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet. doi: 10.1038/ng.2467
109. Chatzikyriakidou A, Voulgari P, Georgiou I, Drosos A (2012) Altered sequence of the ETS1 transcription factor may predispose to rheumatoid arthritis susceptibility. Scand J Rheumatol. doi: 10.3109/03009742.2012.711367
110. Dubois PC, Trynka G, Franke L, Hunt KA, Romanos J, Curtotti A, Zhernakova A, Heap GA, Adany R, Aromaa A, Bardella MT, van den Berg LH, Bockett NA, de la Concha EG, Dema B, Fehrmann RS, Fernandez-Arquero M, Fiatal S, Grandone E, Green PM, Groen HJ, Gwilliam R, Houwen RH, Hunt SE, Kaukinen K, Kelleher D, Korponay-Szabo I, Kurppa K, Macmathuna P, Maki M, Mazzilli MC, McCann OT, Mearin ML, Mein CA, Mirza MM, Mistry V, Mora B, Morley KI, Mulder CJ, Murray JA, Nunez C, Oosterom E, Ophoff RA, Polanco I, Peltonen L, Platteel M, Rybak A, Salomaa V, Schweizer JJ, Sperandeo MP, Tack GJ, Turner G, Veldink JH, Verbeek WH, Weersma RK, Wolters VM, Urcelay E, Cukrowska B, Greco L, Neuhausen SL, McManus R, Barisani D, Deloukas P, Barrett JC, Saavalainen P, Wijmenga C, van Heel DA (2010) Multiple common variants for celiac disease influencing immune gene expression. Nat Genet. doi: 10.1038/ng.543
111. Trynka G, Hunt KA, Bockett NA, Romanos J, Mistry V, Szperl A, Bakker SF, Bardella MT, Bhaw-Rosun L, Castillejo G, de la Concha EG, de Almeida RC, Dias KR, van Diemen CC, Dubois PC, Duerr RH, Edkins S, Franke L, Fransen K, Gutierrez J, Heap GA, Hrdlickova B, Hunt S, Izurieta LP, Izzo V, Joosten LA, Langford C, Mazzilli MC, Mein CA, Midah V, Mitrovic M, Mora B, Morelli M, Nutland S, Nunez C, Onengut-Gumuscu S, Pearce K, Platteel M, Polanco I, Potter S, Ribes-Koninckx C, Ricano-Ponce I, Rich SS, Rybak A, Santiago JL, Senapati S, Sood A, Szajewska H, Troncone R, Varade J, Wallace C, Wolters VM, Zhernakova A, Thelma BK, Cukrowska B, Urcelay E, Bilbao JR, Mearin ML, Barisani D, Barrett JC, Plagnol V, Deloukas P, Wijmenga C, van Heel DA (2011) Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet 43(12):1193-1201. doi: 10.1038/ng.998
112. Du C, Liu C, Kang J, Zhao G, Ye Z, Huang S, Li Z, Wu Z, Pei G (2009) MicroRNA miR-326 regulates T(H)-17 differentiation and is associated with the pathogenesis of multiple sclerosis. Nat Immunol 10(12):1252-1259. doi: 10.1038/ni.1798
113. Luo X, Yang W, Ye DQ, Cui H, Zhang Y, Hirankarn N, Qian X, Tang Y, Lau YL, de Vries N, Tak PP, Tsao BP, Shen N (2011) A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus. PLoS Genet 7(6):e1002128. doi: 10.1371/journal.pgen.1002128
114. Zhou Q, Kijlstra A, Hou S, Yu H, Zhang X, Li X, Xiao X, Yang P (2012) Lack of association of miR-146a and Ets-1 gene polymorphisms with Fuchs uveitis syndrome in Chinese Han patients. Mol Vis 18:426-430
115. Okuducu AF, Zils U, Michaelis SA, Mawrin C, von Deimling A (2006) Increased expression of avian erythroblastosis virus E26 oncogene homolog 1 in World Health Organization grade 1 meningiomas is associated with an elevated risk of recurrence and is correlated with the expression of its target genes matrix metalloproteinase-2 and MMP-9. Cancer 107(6):1365-1372
116. Yamaguchi E, Nakayama T, Nanashima A, Matsumoto K, Yasutake T, Sekine I, Nagayasu T (2007) Ets-1 proto-oncogene as a potential predictor for poor prognosis of lung adenocarcinoma. Tohoku J Exp Med 213(1):41-50 JST.JSTAGE/tjem/213.41 [pii]
117. Pap Z, Pavai Z, Denes L, Kovalszky I, Jung J (2009) An immunohistochemical study of colon adenomas and carcinomas: E-cadherin, Syndecan-1, Ets-1. Pathol Oncol Res 15(4):579-587. doi: 10.1007/s12253-009-9157- x
118. Calli AO, Sari A, Cakalagaoglu F, Altinboga AA, Oncel S (2011) ETS-1 proto-oncogene as a key newcomer molecule to predict invasiveness in laryngeal carcinoma. Pathol Res Pract 207(10):628-633. doi: 10.1016/j.prp.2011.07.010
119. Smith AM, Findlay VJ, Bandurraga SG, Kistner-Griffin E, Spruill LS, Liu A, Golshayan AR, Turner DP (2012) ETS1 transcriptional activity is increased in advanced prostate cancer and promotes the castrate-resistant phenotype. Carcinogenesis 33(3):572-580. doi: 10.1093/carcin/bgs007
120. Sari A, Calli A, Gorgel SN, Altinboga AA, Kara C, Dincel C, Cakalagaoglu F (2012) Immunohistochemical determination of ETS-1 oncoprotein expression in urothelial carcinomas of the urinary bladder. Appl Immunohistochem Mol Morphol 20(2):153-158. doi: 10.1097/PAI.0b013e31821ba035
121. Nagarajan P, Chin SS, Wang D, Liu S, Sinha S, Garrett-Sinha LA (2010) Ets1 blocks terminal differentiation of keratinocytes and induces expression of matrix metalloproteases and innate immune mediators. J Cell Sci 123(Pt 20):3566-3575. doi: 10.1242/jcs.062240
122. Nagarajan P, Parikh N, Garrett-Sinha LA, Sinha S (2009) Ets1 induces dysplastic changes when expressed in terminally-differentiating squamous epidermal cells. PLoS ONE 4(1):e4179. doi: 10.1371/journal.pone.0004179
123. Leprince D, Gegonne A, Coll J, de Taisne C, Schneeberger A, Lagrou C, Stehelin D (1983) A putative second cell-derived oncogene of the avian leukaemia retrovirus E26. Nature 306(5941):395-397
124. Nunn MF, Seeburg PH, Moscovici C, Duesberg PH (1983) Tripartite structure of the avian erythroblastosis virus E26 transforming gene. Nature 306(5941):391-395
125. Domenget C, Leprince D, Pain B, Peyrol S, Li RP, Stehelin D, Samarut J, Jurdic P (1992) The various domains of v-myb and v-ets oncogenes of E26 retrovirus contribute differently, but cooperatively, in transformation of hematopoietic lineages. Oncogene 7(11):2231-2241
126. Ravel-Chapuis P, Leprince D, Pain B, Li R, Domenget C, Stehelin D, Samarut J, Jurdic P (1991) v-myb and v-ets cooperate for the mitogenic stimulation of primary fibroblasts by avian E26 retrovirus. J Virol 65(7):3928-3931
127. Metz T, Graf T (1991) v-myb and v-ets transform chicken erythroid cells and cooperate both in trans and in cis to induce distinct differentiation phenotypes. Genes Dev 5(3):369-380
128. Metz T, Graf T (1991) Fusion of the nuclear oncoproteins v-Myb and v-Ets is required for the leukemogenicity of E26 virus. Cell 66(1):95-105
129. Beug H, Leutz A, Kahn P, Graf T (1984) Ts mutants of E26 leukemia virus allow transformed myeloblasts, but not erythroblasts or fibroblasts, to differentiate at the nonpermissive temperature. Cell 39(3 Pt 2):579-588
130. Bear SE, Bellacosa A, Lazo PA, Jenkins NA, Copeland NG, Hanson C, Levan G, Tsichlis PN (1989) Provirus insertion in Tpl-1, an Ets-1-related oncogene, is associated with tumor progression in Moloney murine leukemia virus-induced rat thymic lymphomas. Proc Natl Acad Sci USA 86(19):7495-7499
131. Bellacosa A, Datta K, Bear SE, Patriotis C, Lazo PA, Copeland NG, Jenkins NA, Tsichlis PN (1994) Effects of provirus integration in the Tpl-1/Ets-1 locus in Moloney murine leukemia virus-induced rat T-cell lymphomas: levels of expression, polyadenylation, transcriptional initiation, and differential splicing of the Ets-1 mRNA. J Virol 68(4):2320-2330
132. Diaz MO, Le Beau MM, Pitha P, Rowley JD (1986) Interferon and c-ets-1 genes in the translocation (9;11)(p22;q23) in human acute monocytic leukemia. Science 231(4735):265-267
133. Sacchi N, Watson DK, Guerts van Kessel AH, Hagemeijer A, Kersey J, Drabkin HD, Patterson D, Papas TS (1986) Hu-ets-1 and Hu-ets-2 genes are transposed in acute leukemias with (4;11) and (8;21) translocations. Science 231(4736):379-382
134. Griffin CA, McKeon C, Israel MA, Gegonne A, Ghysdael J, Stehelin D, Douglass EC, Green AE, Emanuel BS (1986) Comparison of constitutional and tumor-associated 11;22 translocations: nonidentical breakpoints on chromosomes 11 and 22. Proc Natl Acad Sci USA 83(16):6122-6126
135. Rovigatti U, Watson DK, Yunis JJ (1986) Amplification and rearrangement of Hu-ets-1 in leukemia and lymphoma with involvement of 11q23. Science 232(4748):398-400
136. Luster AD, Jhanwar SC, Chaganti RS, Kersey JH, Ravetch JV (1987) Interferon-inducible gene maps to a chromosomal band associated with a (4;11) translocation in acute leukemia cells. Proc Natl Acad Sci USA 84(9):2868-2871
137. Goyns MH, Hann IM, Stewart J, Gegonne A, Birnie GD (1987) The c-ets-1 proto-oncogene is rearranged in some cases of acute lymphoblastic leukaemia. Br J Cancer 56(5):611-613
138. Morris CM, Whitham SE, Fitzgerald PH (1988) Transposition of the oncogene c-ets-1 in a t(11;19)(q23;p13) cell line transient during clonal evolution of blast crisis chronic myeloid leukemia. Leukemia 2(2):74-78
139. Katz F, Malcolm S, Gibbons B, Tilly R, Lam G, Robertson ME, Czepulkowski B, Chessells J (1988) Cellular and molecular studies on infant null acute lymphoblastic leukemia. Blood 71(5):1438-1447
140. Yunis JJ, Jones C, Madden MT, Lu D, Mayer MG (1989) Gene order, amplification, and rearrangement of chromosome band 11q23 in hematologic malignancies. Genomics 5(1):84-90
141. Mitani K, Sato Y, Hayashi Y, Miura Y, Miyagawa K, Yazaki Y, Hirai H (1992) Two myelodysplastic syndrome cases with the inv(11)(p15q23) as a sole chromosomal abnormality. Br J Haematol 81(4):512-515
142. Sulak LE, Clare CN, Morale BA, Hansen KL, Montiel MM (1990) Biphenotypic acute leukemia in adults. Am J Clin Pathol 94(1):54-58
143. Akao Y, Tsujimoto Y, Finan J, Nowell PC, Croce CM (1990) Molecular characterization of a t(11;14)(q23;q32) chromosome translocation in a B-cell lymphoma. Cancer Res 50(16):4856-4859
144. Rowley JD, Diaz MO, Espinosa R 3rd, Patel YD, van Melle E, Ziemin S, Taillon-Miller P, Lichter P, Evans GA, Kersey JH et al (1990) Mapping chromosome band 11q23 in human acute leukemia with biotinylated probes: identification of 11q23 translocation breakpoints with a yeast artificial chromosome. Proc Natl Acad Sci USA 87(23):9358-9362
145. Collyn d'Hooghe M, Galiegue-Zouitina S, Szymiczek D, Lantoine D, Quief S, Loucheux-Lefebvre MH, Kerckaert JP (1993) Quantitative and qualitative variation of ETS-1 transcripts in hematologic malignancies. Leukemia 7(11):1777-1785
146. Koduru PR, Offit K, Jhanwar SC (1989) Molecular analysis of structural chromosome changes affecting chromosome band 11q23. Dis Markers 7(3):145-152
147. Dyer MJ, Fischer P, Nacheva E, Labastide W, Karpas A (1990) A new human B-cell non-Hodgkin's lymphoma cell line (Karpas 422) exhibiting both t (14;18) and t(4;11) chromosomal translocations. Blood 75(3):709-714
148. Miesfeldt S, Kim S, Hanson CA, Bohjanen PR, Leiden JM, Crist WM, Carroll AJ, Thompson CB (1993) DNA fragments of altered electrophoretic mobility in leukemia samples can arise from double-strand DNA breaks at nuclease hypersensitive sites of active genes. Cancer Genet Cytogenet 68(1):34-41 0165-4608(93)90071-S [pii]
149. Kennedy MA, Morris CM, Fitzgerald PH (1989) The oncogene ETS1 is distant from the chromosome 11 breakpoint in leukaemic cells with the t(11;19)(q23;p13). Leuk Res 13(6):459-463
150. Ohyashiki K, Ohyashiki JH, Nomura K, Ryan DH, Kinniburgh AJ, Sandberg AA (1988) Hu-ets-1 gene in congenital leukemia with t(11;19)(q23;p13). Cancer Genet Cytogenet 30(2):233-238
151. Ziemin-van der Poel S, McCabe NR, Gill HJ, Espinosa R 3rd, Patel Y, Harden A, Rubinelli P, Smith SD, LeBeau MM, Rowley JD et al (1991) Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci USA 88(23):10735-10739
152. Yoshida T, Kimura N, Akiyoshi T, Ohshima K, Nagano M, Morioka E, Hisano S, Ohyashiki K, Kamada N, Tamura K (1999) Jumping translocation of homogeneously staining region and tetraploidy with double minutes in acute myelomonocytic leukemia. Cancer Genet Cytogenet 109(1):40-44 S0165460898001447 [pii]
153. Crossen PE, Morrison MJ, Rodley P, Cochrane J, Morris CM (1999) Identification of amplified genes in a patient with acute myeloid leukemia and double minute chromosomes. Cancer Genet Cytogenet 113(2):126-133 S0165460899000187 [pii]
154. Flossbach L, Holzmann K, Mattfeldt T, Buck M, Lanz K, Held M, Moller P, Barth TF (2012) High-resolution genomic profiling reveals clonal evolution and competition in gastrointestinal marginal zone B-cell lymphoma and its large cell variant. Int J Cancer. doi: 10.1002/ijc.27774
155. Pasqualucci L, Trifonov V, Fabbri G, Ma J, Rossi D, Chiarenza A, Wells VA, Grunn A, Messina M, Elliot O, Chan J, Bhagat G, Chadburn A, Gaidano G, Mullighan CG, Rabadan R, Dalla-Favera R (2011) Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet 43(9):830-837. doi: 10.1038/ng.892
156. Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, Johnson NA, Severson TM, Chiu R, Field M, Jackman S, Krzywinski M, Scott DW, Trinh DL, Tamura-Wells J, Li S, Firme MR, Rogic S, Griffith M, Chan S, Yakovenko O, Meyer IM, Zhao EY, Smailus D, Moksa M, Chittaranjan S, Rimsza L, Brooks-Wilson A, Spinelli JJ, Ben-Neriah S, Meissner B, Woolcock B, Boyle M, McDonald H, Tam A, Zhao Y, Delaney A, Zeng T, Tse K, Butterfield Y, Birol I, Holt R, Schein J, Horsman DE, Moore R, Jones SJ, Connors JM, Hirst M, Gascoyne RD, Marra MA (2011) Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature 476(7360):298-303. doi: 10.1038/nature10351
157. Radtke I, Mullighan CG, Ishii M, Su X, Cheng J, Ma J, Ganti R, Cai Z, Goorha S, Pounds SB, Cao X, Obert C, Armstrong J, Zhang J, Song G, Ribeiro RC, Rubnitz JE, Raimondi SC, Shurtleff SA, Downing JR (2009) Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia. Proc Natl Acad Sci USA 106(31):12944-12949. doi: 10.1073/pnas.0903142106
158. Kwon JH, Bae EK, Ahn K-S, Seo M, Yoon S-S, Kim CW, Park S, Kim BK, Kim NK (2003) Expression of the Ets-1 proto-oncogene in diffuse large B cell lymphoma: role as a prognostic factor. Proc Am Soc Clin Oncol 22:abstr 2390
159. Ohyashiki K, Ohyashiki JH, Sandberg AA, Minowada J, Kinniburgh AJ (1987) Loss of a Hu-ets-1 allele in human leukemia cell lines ML-1, -2, and -3 with a chromosome change at 11q24. Cancer Res 47(14):3842-3846
160. Shipley J, Sheer D (1989) Deletion of c-ets1 and T3 gamma loci from the 11q- chromosome in the human monoblastic cell line U937. Leuk Res 13(6):445-450
161. Overbeck BM, Martin-Subero JI, Ammerpohl O, Klapper W, Siebert R, Giefing M (2012) ETS1 encoding a transcription factor involved in B-cell differentiation is recurrently deleted and downregulated in classical Hodgkin lymphoma. Haematologica. doi: 10.3324/haematol.2012.061770
162. Baran-Marszak F, Fagard R, Girard B, Camilleri-Broet S, Zeng F, Lenoir GM, Raphael M, Feuillard J (2002) Gene array identification of Epstein Barr virus-regulated cellular genes in EBV-converted Burkitt lymphoma cell lines. Lab Invest 82(11):1463-1479